These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23219874)

  • 1. Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.
    Chu KS; Hasan W; Rawal S; Walsh MD; Enlow EM; Luft JC; Bridges AS; Kuijer JL; Napier ME; Zamboni WC; DeSimone JM
    Nanomedicine; 2013 Jul; 9(5):686-93. PubMed ID: 23219874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery.
    Zheng D; Li D; Lu X; Feng Z
    Oncol Rep; 2010 Mar; 23(3):717-24. PubMed ID: 20127011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
    Zamboni WC; Strychor S; Joseph E; Parise RA; Egorin MJ; Eiseman JL
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):417-26. PubMed ID: 17957368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles.
    Liu Q; Li RT; Qian HQ; Yang M; Zhu ZS; Wu W; Qian XP; Yu LX; Jiang XQ; Liu BR
    Int J Nanomedicine; 2012; 7():281-95. PubMed ID: 22287839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vive distribution in nude mice.
    Qin Y; Song QG; Zhang ZR; Liu J; Fu Y; He Q; Liu J
    Arzneimittelforschung; 2008; 58(10):529-34. PubMed ID: 19025064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution.
    Ma M; Hao Y; Liu N; Yin Z; Wang L; Liang X; Zhang X
    Int J Nanomedicine; 2012; 7():3389-98. PubMed ID: 22848167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of silybin nanoparticles in mice bearing SKOV-3 human ovarian carcinoma xenocraft.
    Guan XL; Zhao SZ; Hou RJ; Yang SH; Zhang QL; Yin SL; Wang SJ
    Int J Clin Exp Med; 2015; 8(10):17406-17. PubMed ID: 26770331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
    Wang L; Li M; Zhang N
    Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
    Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.
    Sambade M; Deal A; Schorzman A; Luft JC; Bowerman C; Chu K; Karginova O; Swearingen AV; Zamboni W; DeSimone J; Anders CK
    Nanomedicine (Lond); 2016 Aug; 11(15):1947-55. PubMed ID: 27456556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer.
    Gharpure KM; Chu KS; Bowerman CJ; Miyake T; Pradeep S; Mangala SL; Han HD; Rupaimoole R; Armaiz-Pena GN; Rahhal TB; Wu SY; Luft JC; Napier ME; Lopez-Berestein G; DeSimone JM; Sood AK
    Mol Cancer Ther; 2014 Jul; 13(7):1750-7. PubMed ID: 24755199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
    Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
    Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
    Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
    Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the Anti-Ovarian Cancer Activity of Docetaxel by Self-Assemble Micelles and Thermosensitive Hydrogel Drug Delivery System.
    Xu G; Zhu C; Li B; Wang T; Wan J; Zhang Y; Huang J; Yang D; Shen Y
    J Biomed Nanotechnol; 2020 Jan; 16(1):40-53. PubMed ID: 31996284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations.
    Gao X; Wang S; Wang B; Deng S; Liu X; Zhang X; Luo L; Fan R; Xiang M; You C; Wei Y; Qian Z; Guo G
    Biomaterials; 2015; 53():646-58. PubMed ID: 25890760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy.
    Chu KS; Schorzman AN; Finniss MC; Bowerman CJ; Peng L; Luft JC; Madden AJ; Wang AZ; Zamboni WC; DeSimone JM
    Biomaterials; 2013 Nov; 34(33):8424-9. PubMed ID: 23899444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer.
    Ghassami E; Varshosaz J; Minaiyan M; Nasirikenari M; Hoseini SM
    Recent Pat Nanotechnol; 2019; 13(1):49-58. PubMed ID: 30488805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
    Senthilkumar M; Mishra P; Jain NK
    J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.
    Hrkach J; Von Hoff D; Mukkaram Ali M; Andrianova E; Auer J; Campbell T; De Witt D; Figa M; Figueiredo M; Horhota A; Low S; McDonnell K; Peeke E; Retnarajan B; Sabnis A; Schnipper E; Song JJ; Song YH; Summa J; Tompsett D; Troiano G; Van Geen Hoven T; Wright J; LoRusso P; Kantoff PW; Bander NH; Sweeney C; Farokhzad OC; Langer R; Zale S
    Sci Transl Med; 2012 Apr; 4(128):128ra39. PubMed ID: 22491949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.